COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,796 Articles (22,527 medRxiv, 8,269 bioRxiv)

Most recent first Previous |  Page 121: Articles 1201-1210  | Next

Reversible Transcriptomic Age Shifts from Physiological Stress in Whole Blood
Bhak, J., Nam, D., An, K., Kwon, Y., Bhak, J., Jeon, S., Ryu, H.
10.1101/2024.09.08.611853 — Posted: 2024-09-09
COVID-19 real world data infrastructure: A big data resource for study of the impact of COVID-19 in patient populations with immunocompromising conditions
Crawford, J. M., Penberthy, L., Pinto, L. A., Althoff, K. N., Assimon, M. M., Cohen, O., Gillim, L., Hammonds, T. L., Kapur, S., Kaufman, H. W., Kwasny, D., Liew, J. W., Meyer, W. A., Reynolds, S. L., Schleicher, C. B., Subbiah, S., Theruviparampil, C., Wallace, Z. S., Warner, J. L., Yoon, N., Ziemba, Y. C.
10.1101/2024.09.08.24313270 — Posted: 2024-09-09
Epidemiological profile of patients diagnosed with covid-19 in the municipality of Sao Goncalo, Rio de Janeiro, Brazil
das Chagas, R. R., Freitas, H. R., Cardozo, S. V.
10.1101/2024.09.08.24313185 — Posted: 2024-09-09
Adapting COVID-19 research infrastructure to capture influenza and RSV alongside SARS-CoV-2 in UK healthcare workers winter 2022/23: Evaluation of the SIREN Winter Pressures pilot study
Munro, K., Russell, S., Foulkes, S., Broad, J., Sparkes, D., Atti, A., Islam, J., Hopkins, S., Hall, V., SIREN study group
10.1101/2024.09.08.24313279 — Posted: 2024-09-09
Efficacy of Molnupiravir in reducing the risk of severe outcome in patients with SARS-CoV-2 infection: a real-life full-matched case-control study (SAVALO Study).
Gentile, I., Scotto, R., Scirocco, M. M., Di Brizzi, F., Cuccurullo, F., Silvitelli, M., Ametrano, L., Alfe', F. A., Pietroluongo, D., Irace, I., Chiariello, M., De Felice, N., Severino, S., Viceconte, G., Schiano Moriello, N., Maraolo, A. E., Buonomo, A. R., Giaccone, A., Federico II COVID Team
10.1101/2024.09.09.24313305 — Posted: 2024-09-09
Discovery of novel quinoline papain-like protease inhibitors for COVID-19 through topology constrained molecular generative model
Shang, J., Ran, T., Lu, Y., Yang, Q., Zhang, G., Zhou, P., Li, W., Xu, M., Dai, M., Zhong, J., Chen, H., He, P., Zhou, A., Xue, B., Chen, J., Zhang, J., Wu, K., Wu, X., Tang, M., Chen, X., Chen, H.
10.1101/2024.09.07.611841 — Posted: 2024-09-09
A guanidine-based coronavirus replication inhibitor which targets the nsp15 endoribonuclease and combines a direct antiviral effect with subtle boosting of interferon
Van Loy, B., Pujol, E., Kamata, K., Lee, X. Y., Bakirtzoglou, N., Van Berwaer, R., Vandeput, J., Persoons, L., De Wijngaert, B., Goovaerts, Q., Noppen, S., Ahmadzadeh, K., Martin-Lopez, J., Escriche, C., Vanmechelen, B., Krasniqi, B., Singh, A. K., Maes, P., Matthys, P., Dehaen, W., Rozenski, J., Das, K., Voet, A., Vazquez, S., Naesens, L. M., Stevaert, A.
10.1101/2024.09.09.611961 — Posted: 2024-09-09
Forecasting COVID-19, Influenza and RSV hospitalisations over winter 2023/24 in England
Mellor, J., Tang, M. L., Jones, O., Infectious Disease Modelling Team, , Ward, T., Riley, S., Deeny, S. R.
10.1101/2024.09.07.24313175 — Posted: 2024-09-08
Correlates of COVID-19 conspiracy theory beliefs in Japan: A nationally-representative cross-sectional survey
Sato, Y., Kawachi, I., Saijo, Y., Yoshioka, E., Osaka, K., Tabuchi, T.
10.1101/2024.09.06.24313228 — Posted: 2024-09-07
Impact of vaccination on SARS-CoV-2 transmission in the UK: a modelling study
Derqui, N., Mishra, S., Hinsley, W. R., Bhatt, S., Laydon, D. J.
10.1101/2024.09.06.24313210 — Posted: 2024-09-07

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).